Literature DB >> 7616238

Phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) by proline-directed protein kinases and its dephosphorylation.

H Yamamoto1, F Arakane, T Ono, K Tashima, E Okumura, K Yamada, S Hisanaga, K Fukunaga, T Kishimoto, E Miyamoto.   

Abstract

We identified two major substrates for the proline-directed protein kinases--cdc2 kinase and tau protein kinase II (TPKII)--in the cytosol fraction from rat brains. The molecular masses of the proteins were 80 and 46 kDa. Because the 80-kDa protein was phosphorylated by protein kinase C and was heat stable, we examined the possibility that the protein might be myristoylated alanine-rich C kinase substrate (MARCKS). On the basis of a comparison between the properties of the 80-kDa protein and purified MARCKS, we concluded that the 80-kDa protein is indeed MARCKS. The amounts of phosphate incorporated into MARCKS by protein kinase C, cdc2 kinase, and TPKII were 1.7, 1.4, and 0.6 mol/mol of the protein, respectively. Two-dimensional tryptic peptide mapping indicated that phosphorylation sites by protein kinase C and proline-directed protein kinases completely differed. Only the seryl residue was phosphorylated by protein kinase C, whereas both seryl and threonyl residues were phosphorylated by cdc2 kinase and TPKII. Phosphorylation of MARCKS by protein kinase C inhibited the binding to calmodulin, whereas phosphorylation by cdc2 kinase and TPKII significantly increased the binding to calmodulin. The holoenzyme of protein phosphatase 2A dephosphorylated MARCKS that had been phosphorylated by protein kinase C, cdc2 kinase, or TPKII, whereas calcineurin was unable to dephosphorylate it. These results suggest that cdc2 kinase and TPKII regulate the functions of MARCKS in different ways from protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7616238     DOI: 10.1046/j.1471-4159.1995.65020802.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  5 in total

1.  Phosphorylation of the myristoylated protein kinase C substrate MARCKS by the cyclin E-cyclin-dependent kinase 2 complex in vitro.

Authors:  S Manenti; E Yamauchi; O Sorokine; M Knibiehler; A Van Dorsselaer; H Taniguchi; B Ducommun; J M Darbon
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

2.  Development-associated myristoylated alanine-rich C kinase substrate phosphorylation in rat brain.

Authors:  Hideo Hamada; Yun-Ling Zhang; Akiko Kawai; Fang Li; Yasuhide Hibino; Yutaka Hirashima; Masanori Kurimoto; Nakamasa Hayashi; Ichiro Kato; Shunro Endo; Koichi Hiraga
Journal:  Childs Nerv Syst       Date:  2003-01-30       Impact factor: 1.475

Review 3.  Pathophysiological roles of myristoylated alanine-rich C-kinase substrate (MARCKS) in hematological malignancies.

Authors:  Deepak Narayanan Iyer; Omar Faruq; Lun Zhang; Nasrin Rastgoo; Aijun Liu; Hong Chang
Journal:  Biomark Res       Date:  2021-05-06

4.  A novel effect of MARCKS phosphorylation by activated PKC: the dephosphorylation of its serine 25 in chick neuroblasts.

Authors:  Andrea Toledo; Flavio R Zolessi; Cristina Arruti
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

Review 5.  X MARCKS the spot: myristoylated alanine-rich C kinase substrate in neuronal function and disease.

Authors:  Jon J Brudvig; Jill M Weimer
Journal:  Front Cell Neurosci       Date:  2015-10-13       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.